Yes, the stability of temozolomide (TMZ) at neutral pH within nanoparticles can be evaluated by incubating the nanoparticle formulation in phosphate-buffered saline (PBS, pH 7.4) at 37°C, followed by time-dependent quantification of intact TMZ using a validated HPLC or LC-MS/MS method. Samples are collected at predetermined intervals (e.g., 0, 1, 2, 4, 8, 24 hours), centrifuged or filtered to separate nanoparticles if needed, and the supernatant analyzed to detect degradation to 5-aminoimidazole-4-carboxamide (AIC), the major hydrolysis product. A decrease in TMZ concentration over time indicates hydrolysis, and first-order degradation kinetics can be calculated to assess nanoparticle-mediated stabilization relative to free TMZ under identical conditions.
To evaluate the stability of temozolomide (TMZ) at neutral pH (7.4) when encapsulated in nanoparticles, the following protocol can be applied:
TMZ-loaded nanoparticles should be incubated in phosphate-buffered saline (PBS, pH 7.4) at 37°C to mimic physiological conditions. At defined time points (e.g., 0, 1, 2, 4, 8, 24, 48, 72 hours), samples are withdrawn. The nanoparticles are separated using ultracentrifugation or membrane filtration (e.g., 10 kDa filters) to distinguish between the free drug and the encapsulated form.
The concentration of TMZ in both the supernatant (released drug) and the nanoparticle pellet (retained drug) is quantified using HPLC equipped with UV detection at ~330 nm, since TMZ exhibits absorbance in this range. Additionally, LC-MS/MS can be employed to detect TMZ and its hydrolysis product MTIC (5-(3-methyltriazen-1-yl)-imidazole-4-carboxamide) to confirm degradation pathways.
To monitor nanoparticle integrity, techniques such as Dynamic Light Scattering (DLS) for particle size and zeta potential measurement are employed before and after incubation. Transmission Electron Microscopy (TEM) can visualize structural stability of nanoparticles.
By plotting TMZ concentration versus time, degradation kinetics can be determined, and the half-life of TMZ in encapsulated versus free form at pH 7.4 can be calculated. If stability is poor, formulations can be optimized using hydrophobic polymer matrices (like PLGA) or pH-responsive coatings to slow hydrolysis.
This combined analytical approach offers precise insight into the chemical stability of TMZ, the integrity of nanoparticles, and the protective effect of encapsulation at neutral pH.